Human Normal Immunoglobulin — Drug Intelligence | 34 EU Trials

Filter these 34 trials by condition, phase, country and more.

Open in Search →

34 Registered trials

11 Recruiting

18 Completed trials

18 Sponsors

24 Countries

Phase III

Phase II

Phase III: 21 Phase II/III: 3 Phase II: 7 Phase III/IV: 2 Phase I (FiH): 1

Oversight events:

8 temporary halts 3 urgent safety measures across 5 trials

View oversight register →

Indications tested

Primary immunodeficiency syndrome 2 Chronic inflammatory demyelinating polyradiculoneuropathy 2 Plasma cell myeloma 2 Myasthenia gravis 1 Postural orthostatic tachycardia syndrome 1 Kawasaki's disease 1 Infection prophylaxis 1 Secondary immunodeficiency 1 Chronic lymphocytic leukaemia 1 Non-Hodgkin's lymphoma 1

Sponsors using this IMP

Janssen - Cilag International 7 Octapharma Pharmazeutika Produktionsgesellschaft mbH 4 Pfizer Inc. 4 CSL Behring LLC 3 Takeda Development Center Americas Inc. 3 Les Hopitaux Universitaires De Strasbourg 2 Amsterdam UMC Stichting 1 Assistance Publique Hopitaux De Paris 1 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 Grifols Therapeutics LLC 1 Intergroupe Francophone Du Myelome 1 Kyverna Therapeutics Inc. 1

All trials

34 total

IVIGSeN Pending

2022-501717-31-00 Phase II/III 1 country Sorlandet Sykehus HF
Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe… Pending

2024-518420-80-00 Phase III 12 countries Takeda Development Center Americas Inc.
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending

2024-518821-13-00 Phase II 10 countries CSL Behring LLC
Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone … Pending

2025-522756-97-00 Phase II 1 country Region Vaesterbotten; Umea University
Supporting weak immune system during autoimmune therapy: testing Panzyga to prevent infections Pending

2025-522854-37-00 Phase III 8 countries Octapharma Pharmazeutika Produktionsgesellschaft mbH
A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Dem… Recruiting

2024-517450-95-00 Phase III 8 countries Takeda Development Center Americas Inc.
ANACOMP. A RANDOMIZED PHASE III MULTICENTER TRIAL COMPARING THE EFFICACY AND SAFETY OF ANAKINRA VERSUS INTRAVENOUS IMMUNOGLOBULIN (IVIG) RET… Recruiting

2024-516244-25-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A phase 3, open-label, controlled, randomized study of newly diagnosed multiple myeloma treatment, designed to evaluate the efficacy and saf… Recruiting

2024-516418-39-00 Phase III 1 country Intergroupe Francophone Du Myelome
A Phase-2b, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-NMDA Receptor Enc… Recruiting

2023-504686-23-00 Phase II 2 countries Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Generalized Myasthenia Gravis Recruiting

2023-509892-17-00 Phase II/III 1 country Kyverna Therapeutics Inc.
C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL… Recruiting

2023-507871-23-00 Phase III 16 countries Pfizer Inc.
A Randomized, Multi-Center, Parallel, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics o… Recruiting

2022-502193-16-00 Phase III 5 countries Grifols Therapeutics LLC
MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex… Recruiting

2024-514139-50-00 Phase III 12 countries Pfizer Inc.
Efficacy and Safety Study of Nipocalimab for Adults with CIDP Recruiting

2023-508425-28-00 Phase II 8 countries Janssen Cilag International
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination… Recruiting

2023-503442-30-00 Phase III 14 countries Janssen - Cilag International
Intravenous Immunoglobulins for Prevention of BKV Viremia in Kidney Transplant Recipients According to BKV genotype-specific Neutralizing An… Recruiting

2024-515243-37-00 Phase III/IV 1 country Les Hopitaux Universitaires De Strasbourg
Intravenous immunoglobulin and prednisone vs. prednisone in newly diagnosed myositis: a double blind randomized clinical trial Ended

2024-516057-42-00 Phase II 1 country Stichting Amsterdam UMC
A Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Talquetamab in Combination with Teclistamab (Tal-… Ended

2022-502446-27-00 Phase III 13 countries Janssen - Cilag International
Subcutaneous immunoglobulin (HyQvia) against early infections in multiple myeloma: SHIELD Ended

2023-505053-40-00 Phase II 3 countries Lillebaelt Hospital
A Phase 3 Randomized Study Comparing Teclistamab Monotherapy versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethas… Ended

2023-503444-13-00 Phase III 13 countries Janssen - Cilag International
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combin… Ended

2023-503467-41-00 Phase III 9 countries Janssen - Cilag International
A Phase 3 Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant Ended

2023-508897-27-00 Phase III 14 countries Pfizer Inc.
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexa… Ended

2023-503441-55-00 Phase II 10 countries Janssen - Cilag International
MagnetisMM-5: A Phase 3 Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dex… Ended

2023-509208-14-00 Phase III 13 countries Pfizer Inc.

Showing 1–24 of 34 trials

← All drugs A–Z